Share-based Payment Arrangement, Expense of PALISADE BIO, INC. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PALISADE BIO, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • PALISADE BIO, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $85,000, a 7.6% decline year-over-year.
  • PALISADE BIO, INC. annual Share-based Payment Arrangement, Expense for 2024 was $633,000, a 4.5% increase from 2023.
  • PALISADE BIO, INC. annual Share-based Payment Arrangement, Expense for 2023 was $606,000, a 41% decline from 2022.
  • PALISADE BIO, INC. annual Share-based Payment Arrangement, Expense for 2022 was $1,032,000, a 45% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PALISADE BIO, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $85,000 -$7,000 -7.6% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $60,000 -$298,000 -83% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q4 2024 $633,000 $126,000 -$51,000 -29% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $684,000 $92,000 -$100,000 -52% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $784,000 $358,000 +$214,000 +149% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $570,000 $57,000 -$36,000 -39% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $606,000 $177,000 +$91,000 +106% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $515,000 $192,000 -$60,000 -24% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $575,000 $144,000 -$192,000 -57% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $767,000 $93,000 -$265,000 -74% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $1,032,000 $86,000 -$638,000 -88% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $1,670,000 $252,000 +$149,000 +145% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,521,000 $336,000 -$159,000 -32% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,680,000 $358,000 -$211,000 -37% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,891,000 $724,000 -$157,108 -18% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $2,048,108 $103,000 -$561,000 -84% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $2,609,108 $495,000 +$102,000 +26% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $2,507,108 $569,000 +$493,108 +650% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $2,014,000 $881,108 +$761,663 +638% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $1,252,337 $664,000 +$369,400 +125% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $882,937 $393,000 +$264,222 +205% 01 Apr 2020 30 Jun 2020 10-Q 23 Aug 2021 2021 Q2
Q1 2020 $618,715 $75,892 -$262,074 -78% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $880,789 $119,445 +$55,635 +87% 01 Oct 2019 31 Dec 2019 10-K 22 Mar 2021 2020 FY
Q3 2019 $825,154 $294,600 +$159,905 +119% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $665,249 $128,778 -$67,964 -35% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $733,213 $337,966 +$99,131 +42% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $634,082 $63,810 -$202,011 -76% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $836,093 $134,695 -$195,060 -59% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $1,031,153 $196,742 -$455,207 -70% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $1,486,360 $238,835 -$283,604 -54% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $1,769,964 $265,821 -$312,945 -54% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $2,082,909 $329,755 -$249,065 -43% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $2,331,974 $651,949 -$165,118 -20% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 $2,497,092 $522,439 -$948,447 -64% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $3,445,539 $578,766 -$251,553 -30% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $3,697,092 $578,820 -$226,412 -28% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $3,923,504 $817,067 +$191,108 +31% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $3,732,396 $1,470,886 +$781,029 +113% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $2,951,367 $830,319 01 Oct 2015 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q3 2015 $805,232 +$148,285 +23% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $625,959 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $689,857 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q3 2014 $656,947 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q3 2012 $486,700 -$180,924 -27% 01 Jul 2012 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $330,713 -$727,702 -69% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q3 2011 $667,624 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $1,058,415 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2

PALISADE BIO, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $633,000 +$27,000 +4.5% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $606,000 -$426,000 -41% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $1,032,000 -$859,000 -45% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $1,891,000 -$123,000 -6.1% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $2,014,000 +$1,133,211 +129% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $880,789 +$246,707 +39% 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2021 2020 FY
2018 $634,082 -$1,135,882 -64% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $1,769,964 -$1,675,575 -49% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $3,445,539 +$494,172 +17% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $2,951,367 -$1,368,706 -32% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2017 2016 FY
2014 $4,320,073 +$1,988,672 +85% 01 Jan 2014 31 Dec 2014 10-K 14 Mar 2016 2015 FY
2013 $2,331,401 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.